Insider Trading Activity athenahealth, Inc. (NASDAQ:ATHN) – CEO Sold 4,000 shares of Stock

Insider Trading Activity For athenahealth, Inc. (NASDAQ:ATHN)

Jonathan Bush , CEO of athenahealth, Inc. (NASDAQ:ATHN) reportedly Sold 4,000 shares of the company’s stock at an average price of 143.31 for a total transaction amount of $573,240.00 SEC Form

Insider Trading History For athenahealth, Inc. (NASDAQ:ATHN)

On 8/10/2012 Robert Cosinuke, CMO, sold 3,000 with an average share price of $92.35 per share and the total transaction amounting to $277,050.00.View SEC Filing

On 2/26/2013 David Eric Robinson, Director, sold 10,000 with an average share price of $90.13 per share and the total transaction amounting to $901,300.00.View SEC Filing

On 5/1/2013 Jonathan Bush, CEO, sold 5,000 with an average share price of $95.70 per share and the total transaction amounting to $478,500.00.View SEC Filing

On 5/10/2013 Robert Cosinuke, CMO, sold 6,000 with an average share price of $84.80 per share and the total transaction amounting to $508,800.00.View SEC Filing

On 6/3/2013 Jonathan Bush, CEO, sold 5,000 with an average share price of $84.39 per share and the total transaction amounting to $421,950.00.View SEC Filing

On 6/3/2013 Daniel H Orenstein, SVP, sold 1,000 with an average share price of $84.22 per share and the total transaction amounting to $84,220.00.View SEC Filing

On 6/10/2013 Robert Cosinuke, CMO, sold 6,000 with an average share price of $85.74 per share and the total transaction amounting to $514,440.00.View SEC Filing

Analyst Ratings For athenahealth, Inc. (NASDAQ:ATHN)
These are 2 Sell Ratings, 10 Hold Ratings, 12 Buy Ratings .
The current consensus rating for athenahealth, Inc. (NASDAQ:ATHN) is Hold (Score: 2.42) with a consensus target price of $147.38 , a potential (4.02% upside)

Analyst Ratings History For athenahealth, Inc. (NASDAQ:ATHN)

• On 10/21/2015 Avondale Partners Initiated Coverage of rating Market Perform with a price target of $175.00
• On 10/23/2015 Raymond James Financial, Inc. Upgraded rating Market Perform to Outperform with a price target of $160.00
• On 2/8/2016 Topeka Capital Markets Upgraded rating Hold to Buy with a price target of $169.00 to $160.00
• On 2/8/2016 Goldman Sachs Group, Inc. (The) Lower Price Target of rating Neutral with a price target of $155.00 to $149.00
• On 7/22/2016 Deutsche Bank AG Downgraded rating Buy to Hold with a price target of $165.00 to $147.00
• On 7/22/2016 FBR & Co Lower Price Target of rating Market Perform with a price target of $145.00 to $140.00
• On 1/3/2017 Royal Bank Of Canada Initiated Coverage of rating Outperform

Recent Trading Activity for athenahealth, Inc. (NASDAQ:ATHN)
Shares of athenahealth, Inc. closed the previous trading session at 141.68 down -3.72 -2.56% with 608,852 shares trading hands.